Eliem Therapeutics ( NASDAQ:ELYM – Get Rating ) and Avidity Biosciences ( NASDAQ:RNA – Get Rating ) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends and institutional ownership. Profitability This table compares Eliem Therapeutics and Avidity Biosciences' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Eliem Therapeutics N/A -31.

https://www.dailypolitical.com/2023/05/07/eliem-therapeutics-nasdaqelym-and-avidity-biosciences-nasdaqrna-critical-contrast.html

#dailypolitical